Fact CheckerSign in

NCT06729125Completed

Transcranial Photobiomodulation With Patients With Parkinson's Disease

Posture Stability and Functional Activity Changes After Transcranial Photobiomodulation for Patients With Parkinson's Disease: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 8 Apr 2025

Brief summary (registry, in English)

Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's disease. It is a progressive and disabling disease with significative impact on quality of life. Since it has no cure, available treatment is targeted to improve the symptoms due to a lack of dopamine in the central nervous system. The aim of the study was to see how transcranial photobiomodulation (tPBM) helped patients with Parkinson's disease.

Status (registry)
Completed
Study type
Interventional
Enrollment
38 (actual)
First submitted
5 Dec 2024
Start date
15 Dec 2024
Primary completion date
20 Mar 2025
Lead sponsor
Al-Zaytoonah University of Jordan
NCT number
NCT06729125

What you commit to

  • Study type: Interventional
  • Participants enrolled: 38
  • From 15 Dec 2024 to the primary completion date, 20 Mar 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • chronic diseases not medically controlled and participation in another physiotherapy program or sport activity during the intervention period or in the month before starting the study

Other

  • comorbidities that affect balance or walking,
  • other neurological pathologies besides PD,

Who the study is looking for

  • idiopathic PD,
  • Hoehn \& Yahr stage I-IV,
  • independent gait with or without technical assistance
  • stable parkinsonian medication for at least a month before the study star.

Age in the registry: 50 years to 70 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Al Zaytoonah University
Coordinator of this site? Confirm its status
AmaanJordanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.